Differential Clinical Features in Colombian Patients With Rolandic Epilepsy and Suggestion of Unlikely Association With GRIN2A,RBFOX1,or RBFOX3 Gene Variants
Restricted accessResearch articleFirst published online September, 2021
Differential Clinical Features in Colombian Patients With Rolandic Epilepsy and Suggestion of Unlikely Association With GRIN2A,RBFOX1,or RBFOX3 Gene Variants
Our purpose was to describe the phenotypic features and test for association of genes GRIN2A, RBFOX1 and RBFOX3 with rolandic epilepsy in patients from Colombia.
Methods:
Thirty patients were enrolled. A structured interview was applied. In addition, saliva samples were collected from the patients and their parents. One polymorphism in each of GRIN2A, RBFOX1 and RBFOX3 genes was tested.
Results:
The average age at onset was 5.3 years. Almost half the sample presented prolonged seizures (>5 minutes); although the majority of the patients presented their seizures only while asleep, over a quarter presented them only while awake. The most frequent comorbidity was the presence of symptoms compatible with attention-deficit hyperactivity disorder (ADHD). Personal history of febrile seizures and parasomnias were equally frequent (20%). Family history of any type of epilepsy was reported in 80% of the patients, followed by migraine (73.3%) and poor academic performance (63.3%). About half the sample reported sleepwalking in parents or sibs. Most patients had received pharmacologic treatment. We found no association of rolandic epilepsy with the single nucleotide polymorphisms tested.
Conclusions:
Our rolandic epilepsy cohort presents clinical features clearly different from other cohorts. For instance, age at onset is much earlier in our set of patients, and personal and family history of febrile seizures as well as parasomnias are highly prevalent in our sample. No association of rolandic epilepsy with variants at the 3 genes tested was found. This lack of association may reflect the high genetic heterogeneity of the epilepsies.
LarssonKEeg-OlofssonO. A population based study of epilepsy in children from a Swedish county. Eur J Paediatr Neurol. 2006;10(3):107–113.
2.
BeaussartM.Benign epilepsy of children with rolandic (centro-temporal) paroxysmal foci. A clinical entity. Study of 221 cases. Epilepsia. 1972;13(6):795–811.
3.
PanayiotopoulosCPMichaelMSandersSValetaTKoutroumanidisM. Benign childhood focal epilepsies: assessment of established and newly recognized syndromes. Brain. 2008;131(9):2264–2286.
4.
MaCKLChanKY. Benign childhood epilepsy with centrotemporal spikes: a study of 50 Chinese children. Brain Dev. 2003;25(6):390–395.
5.
BergATShinnarSLevySRTestaFM. Newly diagnosed epilepsy in children: presentation at diagnosis. Epilepsia. 1999;40(4):445–452.
6.
KramerUZelnikNLerman-SagieTShaharE. Benign childhood epilepsy with centrotemporal spikes: clinical characteristics and identification of patients at risk for multiple seizures. J Child Neurol. 2002;17(1):17–19.
7.
BerroyaAMBleaselAFStevermuerTLLawsonJByeAME. Spike morphology, location, and frequency in benign epilepsy with centrotemporal spikes. J Child Neurol. 2005;20(3):188–194.
8.
MassaRde Saint-MartinACarcangiuR, et al.EEG criteria predictive of complicated evolution in idiopathic rolandic epilepsy. Neurology. 2001;57(6):1071–1079.
9.
GobbiGBoniAFilippiniM. The spectrum of idiopathic rolandic epilepsy syndromes and idiopathic occipital epilepsies: from the benign to the disabling. Epilepsia. 2006;47(suppl 2):62–66.
10.
KramerU. Atypical presentations of benign childhood epilepsy with centrotemporal spikes: a review. J Child Neurol. 2008;23(7):785–790.
11.
PanayiotopoulosCP. A Clinical Guide to Epileptic Syndromes and Their Treatment. London: Springer; 2010.
12.
RudolfGValentiMPHirschESzepetowskiP. From rolandic epilepsy to continuous spike-and-waves during sleep and Landau-Kleffner syndromes: insights into possible genetic factors. Epilepsia. 2009;50(suppl 7):25–28.
13.
CamfieldCSCamfieldPR. Rolandic epilepsy has little effect on adult life 30 years later: a population-based study. Neurology. 2014;82(13):1162–1166.
14.
LoiseauPBeaussartM. Hereditary factors in partial epilepsy. Epilepsia. 1969;10(1):23–31.
15.
VearsDFTsaiMHSadleirLG, et al.Clinical genetic studies in benign childhood epilepsy with centrotemporal spikes. Epilepsia. 2012;53(2):319–324.
16.
VadlamudiLHarveyASConnellanMM, et al.Is benign rolandic epilepsy genetically determined?Ann Neurol. 2004;56(1):129–132.
17.
BobbiliDRLalDMayP, et al.Exome-wide analysis of mutational burden in patients with typical and atypical rolandic epilepsy. Eur J Hum Genet. 2018;26(2):258–264.
18.
LalDPernhorstKKleinKM, et al.Extending the phenotypic spectrum of RBFOX1 deletions: sporadic focal epilepsy. Epilepsia. 2015;56(9):e129–e133.
19.
LalDReinthalerEMAltmüllerJ, et al.RBFOX1 and RBFOX3 mutations in rolandic epilepsy. PLoS One. 2013;8(9):e73323.
20.
YangXQianPXuX, et al.GRIN2A mutations in epilepsy-aphasia spectrum disorders. Brain Dev. 2018;40(3):205–210.
21.
LescaGRudolfGBruneauN, et al.GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction. Nat Genet. 2013;45(9):1061–1066.
22.
LemkeJRLalDReinthalerEM, et al.Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Nat Genet. 2013;45(9):1067–1072.
23.
DimassiSLabalmeALescaG, et al.A subset of genomic alterations detected in rolandic epilepsies contains candidate or known epilepsy genes including GRIN2A and PRRT2. Epilepsia. 2014;55(2):370–378.
24.
LalDTrucksHMøllerRS, et al.Rare exonic deletions of the RBFOX1 gene increase risk of idiopathic generalized epilepsy. Epilepsia. 2013;54(2):265–271.
25.
FogelBLWexlerEWahnichA, et al.RBFOX1 regulates both splicing and transcriptional networks in human neuronal development. Hum Mol Genet. 2012;21(19):4171–4186.
26.
AddisLSprovieroWThomasS V, et al.Identification of new risk factors for rolandic epilepsy: CNV at Xp22.31 and alterations at cholinergic synapses. J Med Genet. 2018;55(9):607–616.
27.
BoscariolMCasaliRLAmaralMIR, et al.Language and central temporal auditory processing in childhood epilepsies. Epilepsy Behav. 2015;53:180–183.
28.
MatosMBaraTClarkSZeigelboimBSMarquesJMLiberalessoPBN. Benign rolandic epilepsy of childhood and central auditory processing disorder: a noncasual neurophysiological association. Epilepsy Behav. 2018;89:55–58.
29.
RamosLLPMonteiroFPSampaioLPB, et al.Heterozygous loss of function of NR4A2 is associated with intellectual deficiency, rolandic epilepsy, and language impairment. Clin Case Rep. 2019;7(8):1582–1584.
30.
OliveiraEPNeriMLCapelattoLLGuimarãesCAGuerreiroMM. Rolandic epilepsy and dyslexia. Arq Neuropsiquiatr. 2014;72(11):826–831.
31.
MildredYOvallesBCornejo SánchezD, et al.Caracterización de la epilepsia benigna de la infancia con puntas centrotemporales [Characterization of childhood benign epilepsy with centrotemporal spikes]. Medicina (B Aires). 2017;39(4):299–313.
32.
Pérez-Palma eduardoHelbigIKleinKM, et al.Heterogeneous contribution of microdeletions in the development of common generalised and focal epilepsies. J Med Genet. 2017;54(9):598–606.
33.
Cornejo-SanchezDMCarrizosa-MoogJCabrera-HemerD, et al.Sleepwalking and sleep paralysis: prevalence in Colombian families with genetic generalized epilepsy. J Child Neurol. 2019;34(9):491–498.
34.
BarrettJCFryBMallerJDalyMJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263–265.
35.
ChangCCChowCCTellierLCVattikutiSPurcellSMLeeJJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4(1):7.
36.
Durá TravéTYoldi PetriMEGallinas VictorianoFGarcía de GurtubaI, Gallizo. Epilepsia rolándica: características epidemiológicas, clínicas y evolutivas [Rolandic epilepsy: epidemiologic, clinical and evolutionary characteristics]. An Pediatría. 2008;68(5):466–473.
37.
BoumaPADBovenkerkACWestendorpRGJBrouwerOF. The course of benign partial epilepsy of childhood with centrotemporal spikes: a meta-analysis. Neurology. 1997;48(2):430–437.
38.
FejermanN. Benign focal epilepsies in infancy, childhood and adolescence [Spanish]. Rev Neurol. 2002;34(1):7–18.
39.
LeeYJHwangSKKwonS. The clinical spectrum of benign epilepsy with centro-temporal spikes: a challenge in categorization and predictability. J Epilepsy Res. 2017;7(1):1–6.
40.
CallenbachPMCBoumaPADGeertsAT, et al.Long term outcome of benign childhood epilepsy with centrotemporal spikes: Dutch Study of Epilepsy in Childhood. Seizure. 2010;19(8):501–506.
41.
DaiAIDemiryürekS. The clinical implications of Todd paralysis in children with benign rolandic epilepsy. J Child Neurol. 2016;31(3):289–293.
42.
RossEEStoyellSMKramerMABergATChuCJ. The natural history of seizures and neuropsychiatric symptoms in childhood epilepsy with centrotemporal spikes (CECTS). Epilepsy Behav. 2020;103(pt A):106437.
43.
FisherRSCrossJHFrenchJA, et al.Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):522–530.
44.
FilippiniMBoniAGiannottaMGobbiG. Neuropsychological development in children belonging to BECTS spectrum: long-term effect of epileptiform activity. Epilepsy Behav. 2013;28(3):504–511.
45.
NorthcottEConnollyAMBerroyaA, et al.The neuropsychological and language profile of children with benign rolandic epilepsy. Epilepsia. 2005;46(6):924–930.
46.
WirrellEC. Benign epilepsy of childhood with centrotemporal spikes. Epilepsia. 1998;39(suppl 4):S32–S41.
47.
WirrellECHamiwkaLD. Do children with benign rolandic epilepsy have a higher prevalence of migraine than those with other partial epilepsies or nonepilepsy controls?Epilepsia. 2006;47(10):1674–1681.
48.
DiazRRuanoMIChaconA. A study of sleep disorders in Caldas, Colombia. Acta Medica Colomb. 2009;34(2):66–72.
49.
SmithABKavrosPMClarkeTDortaNJTremontGPalDK. A neurocognitive endophenotype associated with rolandic epilepsy. Epilepsia. 2012;53(4):705–711.
50.
ParisiPPaolinoMCRaucciUFerrettiAVillaMPTreniteDK-N. “Atypical forms” of benign epilepsy with centrotemporal spikes (BECTS): how to diagnose and guide these children. A practical/scientific approach. Epilepsy Behav. 2017;75:165–169.
51.
PetersJMCamfieldCSCamfieldPR. Population study of benign rolandic epilepsy. Neurology. 2001;57(3):537–539.
52.
HughesJR. Benign epilepsy of childhood with centrotemporal spikes (BECTS): to treat or not to treat, that is the question. Epilepsy Behav. 2010;19(3):197–203.
53.
TanHJSinghJGuptaRde GoedeC. Comparison of antiepileptic drugs, no treatment, or placebo for children with benign epilepsy with centrotemporal spikes. Cochrane Database Syst Rev. 2014;2014(9):CD006779.
54.
Asadi-PooyaAAForouzeshMEidiHMirzaghafourSE. Levetiracetam versus carbamazepine in treatment of rolandic epilepsy. Epilepsy Behav. 2019;94:1–8.
55.
NeubauerBAFiedlerBHimmeleinB, et al.Centrotemporal spikes in families with rolandic epilepsy Linkage to chromosome 15q14. Neurology. 1998;51:1608–1613.
56.
StrugLJClarkeTChiangT, et al.Centrotemporal sharp wave EEG trait in rolandic epilepsy maps to Elongator Protein Complex 4 (ELP4). Eur J Hum Genet. 2009;17(9):1171–1181.
57.
XiongWZhouD. Progress in unraveling the genetic etiology of rolandic epilepsy. Seizure Eur J Epilepsy. 2017;47:99–104.
